Pimple Killer Genomma Advances Most Since 2009 After Earnings

  • Stock climbs after sales, profit exceed analysts' forecasts
  • Company reports stronger-than-expected revenue in U.S., Mexico

Genomma Lab Internacional SAB, the Mexican seller of remedies for acne and baldness, jumped the most since May 2009 after earnings beat analysts’ estimates.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.